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Salmonella spp. are gram-negative flagellated bac-
teria that can cause food- and waterborne gastroen-
teritis and typhoid fever in humans. We now report
that flagellin from Salmonella spp. is recognized in
mouse intestine by Toll-like receptor 11 (TLR11).
Absence of TLR11 renders mice more susceptible
to infection by S. Typhimurium, with increased dis-
semination of the bacteria and enhanced lethality.
Unlike S. Typhimurium, S. Typhi, a human obligatory
pathogen that causes typhoid fever, is normally
unable to infect mice. TLR11 is expressed in mice,
but not in humans, and remarkably, we find that
tlr11/ mice are efficiently infected with orally
administered S. Typhi. We also find that tlr11/
mice can be immunized against S. Typhi. Therefore,
tlr11/ mice represent a small-animal model for
the study of the immune response to S. Typhi and
for the development of vaccines against this impor-
tant human pathogen.INTRODUCTION
Innate immune responses provide the first line of host defense
against microbial pathogens and, together with adaptive immu-
nity, ensure effective clearance of invading pathogens. Toll-like
receptors (TLRs), which are expressed in sentinel cells such as
macrophages and dendritic cells, recognize conserved compo-
nents of microbes known as pathogen-associated molecular
patterns (PAMPs) (Kawai and Akira, 2010). Mice express 12
TLRs, including TLRs 11, 12, and 13, which are not expressed
in humans (Roach et al., 2005). We have previously character-
ized the role of the mouse-specific TLR11 in response to uropa-
thogenic E. coli and the apicomplexan parasite Toxoplasma
gondii (Yarovinsky et al., 2005; Zhang et al., 2004). The590 Cell 151, 590–602, October 26, 2012 ª2012 Elsevier Inc.T. gondii PAMP recognized by TLR11 is the apicomplexan
profilin protein (Yarovinsky et al., 2005). The finding that TLR11
recognized a protein ligand from T. gondii was consistent with
phylogenetic analyses demonstrating that TLR11 is most closely
related to TLR5 (Roach et al., 2005; Zhang et al., 2004), which
recognizes the bacterial protein PAMP, flagellin (Hayashi et al.,
2001).
In contrast to T. gondii, the ligand from uropathogenic E. coli
(UPECs) that triggers innate responses through TLR11 in the
urogenital tract has remained uncharacterized (Zhang et al.,
2004). Our initial efforts in purifying this ligand suggested that it
was a protein component of UPEC, although we were not able
to identify the specific molecule recognized by TLR11 (Zhang
et al., 2004). Given that PAMPs are rarely restricted to specific
pathogens (Kawai and Akira, 2010), we chose to investigate
the potential role of TLR11 in recognizing other pathogens in
order to identify another source from which we could potentially
purify the bacterial ligand for TLR11. Consistent with TLR11
mediating the innate response to UPECs at the urogenital epithe-
lium, we noted that TLR11 is also highly expressed in the intes-
tinal epithelium. This led us to speculate that TLR11 might also
function in the recognition of enteropathogenic bacteria.
Gram-negative Salmonella sp. is a common bacterial entero-
pathogen and is widely used in laboratory studies aimed toward
understanding the basis of mucosal immune responses and
diseases such as gastroenteritis and typhoid. Most laboratory
studies are carried out using S. Typhimurium in mice, where
a disseminated infection with some similarities to human typhoid
is observed. Typhoid fever affects more than 20 million individ-
uals and causes more than 220,000 deaths annually (Crump
et al., 2004; Woc-Colburn and Bobak, 2009). However, typhoid
disease in humans is caused by the specific Salmonella enterica
serovars Typhi and, to a lesser extent, Paratyphi (Crump et al.,
2004), which do not infect mice. There are marked genetic differ-
ences between S. Typhimurium and S. Typhi, which presumably
account for the divergent disease states caused by these organ-
isms in people (Sabbagh et al., 2010). As a result, animal models
of S. Typhi infection are of significant interest for understanding
the biology of this important pathogen. Typhoid is endemic in
third world countries, where it has been difficult to achieve
adequate improvements in sanitation and water supply to have
a timely impact on the disease. Clearly, what is required are
effective vaccination strategies. Unfortunately, the two approved
vaccines have only modest efficacy (50%–80% protection)
(Guzman et al., 2006). The development of better vaccination
would require a more complete understanding of the immune
response to bacteria as well as the availability of experimentally
tractable small-animal models that can be infected by S. Typhi.
In this study, we describe the contribution of TLR11 in
Salmonella spp. infection of the mouse. We have found that
TLR11-deficient mice are severely compromised in innate
epithelial responses to S. Typhimurium and exhibit poorly con-
trolled and widely disseminated infection, resulting in enhanced
lethality. We have purified the ligand from S. Typhimurium and
found that, like TLR5, TLR11 recognizes flagellin. Flagellin is
also the TLR11 ligand from UPECs. Flagellin binds TLR11 and
induces innate responses in mice independent of TLR5. Re-
markably, loss of TLR5 results in upregulation of TLR11 in lamina
propria macrophages, suggesting that enhanced TLR11
responses may contribute to the resistance of TLR5-deficient
mice to S. Typhimurium infection. Because TLR11 contributes
significantly to protection of mice from S. Typhimurium and the
presence of TLR11 correlates with the host restriction of typhoi-
dal Salmonella infection, we tested whether TLR11 might be
responsible for mouse resistance to S. Typhi infection. As for
S. Typhimurium, we found that TLR11 recognized S. Typhi
flagellin and that S. Typhi could lethally infect mice lacking
TLR11 upon oral infection. Low-dose oral infection with
S. Typhi produced a febrile illness with features of human
typhoid. Existing small-animal models of S. Typhi infection rely
on use of severely immunocompromised animals (Mian et al.,
2011) and, therefore, cannot serve as systems in which to study
host responses or for vaccine development. In contrast, TLR11-
deficient mice can be protected from infection by vaccination
with heat-killed S. Typhi or by passive transfer of serum from
immunized mice. Therefore, these results provide genetic
evidence of host restriction enforced by species-specific TLR
expression and the generation of an immunologically intact
model for assessing S. Typhi host-pathogen interactions and
testing new vaccine approaches.
RESULTS
Lack of TLR11 Leads to Enhanced Susceptibility
to Infection by S. Typhimurium
Although we had previously suggested that the PAMP from
UPECs recognized by TLR11 was a protein (Zhang et al.,
2004), our initial efforts to identify the ligand were unfruitful. We
suspected that TLR11 was likely to recognize similar ligands in
other pathogenic bacteria, and to help identify additional patho-
gens that might trigger TLR11-dependent responses, we exam-
ined the tissue distribution of TLR11. We carried out RT-PCR to
examine TLR11 expression in liver, spleen, kidney, heart, and
intestine and observed high relative expression of TLR11 in the
small intestine (Figure 1A and Figure S1A available online). We
examined the expression of TLR11 in sections from the smallintestine by using in situ hybridization. Similar to the pattern of
expression seen in the urinary bladder, TLR11 messenger RNA
(mRNA) was strongly enriched in the epithelial layer of the small
intestine (Figures 1B and S1B).
The intestinal localization of TLR11 suggested that TLR11
might recognize enteropathogens. Aswe had established recog-
nition of E. coli spp. by TLR11 (Zhang et al., 2004), we wished to
determine whether other well-known intestinal pathogens might
be recognized by TLR11. Salmonella spp. are medically relevant
enteropathogenic bacteria, and S. Typhimurium is widely used in
mouse studies. Given that TLR11 was expressed at the small
intestinal epithelium through which S. Typhimurium gains entry
to the host and that it was also expressed in the macrophage
populations in which S. Typhimurium is found, we tested
whether TLR11 was important for immune responses to orally
administered S. Typhimurium, to which mice are susceptible.
As reported previously, oral administration of high doses of
S. Typhimurium led to infection and lethality in wild-type mice;
however, the lethality was significantly enhanced in tlr11/
mice (Figure 1C). Histological studies demonstrated enhanced
destruction of the intestinal wall in mice lacking TLR11, which
is consistent with an important role in epithelial immunity (Fig-
ure 1D). By using S. Typhimurium expressing green fluorescent
protein (GFP), we were able to observe increased bacterial
dissemination that spread beyond the severely damaged intes-
tinal wall in tlr11/ mice (Figure 1E). Significantly increased
recovery of viable S. Typhimurium from the liver, spleen, and
kidney of tlr11/ mice confirmed the enhanced dissemination
in the absence of TLR11 (Figure 1F). Identical results, including
intestinal damage and dissemination, were seen with non-
GFP-expressing S. Typhimurium (Figure S1C). Analyses of
serum cytokine levels revealed elevated IL-12 (Figure 1G), IL-6
(Figure 1H), and TNF (Figure 1I) in tlr11/ mice, suggesting
that bacterial dissemination causes death of the animals by trig-
gering a cytokine storm.
Flagellin Is a Ligand for TLR11
The TLR11 stimulatory activity found in lysates of the UPEC
strain 8NU has a protein component, as this activity is abolished
by treatment with proteinase K, but not RNase, DNase, or
concanavalin A (ConA) (Zhang et al., 2004). Based on this
finding, we speculated that the TLR11 PAMP in Salmonella
also had a protein component that could be isolated by column
chromatography. We fractionated heat-killed lysates of
S. Typhimurium on a DEAE-Sephacel anion-exchange column,
followed by CM-sepharose cation exchange chromatography
and finally Mono Q FPLC chromatography using linear NaCl
gradients (Figure 2A). The stimulatory activity of dialyzed frac-
tions from each chromatographic step was tracked by testing
induction of luciferase in RAW cells, which express TLR11,
stably transfected with an NF-kB-luciferase reporter. The stim-
ulatory activity eluted broadly and corresponded to the two
major protein peaks (fraction 8 and fraction 14) following
Mono Q fractionation (Figure 2B). To confirm that the stimula-
tory activity in these fractions was of a similar nature to the
TLR11 PAMP, we treated fraction 8 and fraction 14 with DNase,
RNase, and proteinase K. As lipopolysaccharide (LPS) is a major
PAMP in gram-negative bacteria, we also depleted LPS byCell 151, 590–602, October 26, 2012 ª2012 Elsevier Inc. 591
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Figure 1. TLR11 Is Expressed in Intestine and Protects against S. Typhimurium
(A) RT-PCR analysis of TLR11 in various organs.
(B) In situ hybridization staining (antisense) for TLR11 in small-intestine tissue section.
(C) Survival of wt and tlr11/ mice (n = 7) orally infected with S. Typhimurium (108 CFU).
(D) Tissue damage during S. Typhimurium infection shown by H&E staining in small intestine, spleen, and kidney on day 5 postinfection.
(E) Intestinal invasion of S. Typhimurium expressing GFP.
(F) Dissemination of GFP S. Typhimurium in orally infected WT or tlr11/mice was detected on day 5 postinfection by measuring CFU per gram of spleen, liver,
and kidney.
(G–I) Day 5 serum cytokines from WT or tlr11/ mice orally infected with S. Typhimurium measured by ELISA. *p < 0.001.
Related to Figure S1.using polymyxin B sepharose. As shown in Figure 2C, the
NF-kB stimulatory activity in fraction 8 was unaffected by
DNase, RNase, and proteinase K but was severely diminished
by polymyxin B treatment, and hence, the activity in fraction 8
is likely due to LPS. In contrast, the stimulatory activity in frac-
tion 14 was unaffected by DNase, RNase, and polymyxin B but
was abolished by proteinase K treatment, strongly suggesting
a protein PAMP.
To test the specificity of these fractions for TLR11, we
measured the induction of IL6 following stimulation of peritoneal
macrophages from either wild-type (WT) or tlr11/ mice. The
stimulatory activity in fraction 8 was unaffected by the absence
of TLR11; however, the ability of fraction 14 to stimulate IL6
production was completely abolished in the tlr11/ cells (Fig-
ure 2D) or upon treatment with proteinase K (Figure S2A). There-
fore, fraction 14 contains a Salmonella-derived protein with
TLR11-dependent stimulatory activity. SDS-PAGE analysis of
fraction 14 revealed few protein bands but included a prominent
band around 50 kDa with an elution pattern that matched the
TLR11-dependent activity (Figures 2A and 2B). We excised
that band and analyzed it by mass spectrometry, and surpris-592 Cell 151, 590–602, October 26, 2012 ª2012 Elsevier Inc.ingly, the only protein detected was S. Typhimurium flagellin
(Figure S2B).
Although the stimulatory activity observed in fraction 14 was
dependent upon the expression of TLR11 (Figures 2D and
S2A), we were concerned that stimulation might occur through
the known flagellin receptor, TLR5. However, consistent with
previous reports (West et al., 2005), we found that the mouse
macrophage cell line RAW 264.7 does not express TLR5 (Fig-
ure 2B, inset), suggesting that the stimulation by fraction 14
(and hence flagellin) was not due to TLR5. The recognition of
Salmonella flagellin by TLR5 is believed to be important for
mounting of innate responses to this bacteria (Fournier et al.,
2009; Uematsu et al., 2006), although the role of TLR5 is not
straightforward; mice lacking TLR5 show enhanced resistance
to S. Typhimurium (Uematsu et al., 2006). Our results suggested
that TLR11 might play a more significant role in murine resis-
tance to S. Typhimurium.
Our previous results had demonstrated that UPEC also
possess a proteinase-K-sensitive ligand recognized by TLR11.
We therefore carried out an independent purification similar to
that used for S. Typhimurium. The peak, proteinase-K-sensitive,
CB
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A Figure 2. TLR11RecognizesS.Typhimurium
Flagellin
(A) The TLR11 ligand was purified by mechanical
disruption of S. Typhimurium followed by
sequential DEAE-sephacel and CM-Sephacel
chromatography. Fractions with stimulatory
activity in Raw-kB-luc cells were further subjected
to MonoQ FPLC with a linear NaCl gradient.
Shown is absorbance at 280 nm over the course of
the elution. The fractions indicated were resolved
by SDS PAGE, and proteins were visualized by
Coomassie staining.
(B) Stimulatory activity of MonoQ fractions was
assessed in Raw-kB-luc cells.
(C) Fractions 8 and 14 were subjected to DNase,
RNase, Proteinase K, and Polymixin B treatment
and assessed for stimulatory activity in Raw-kB-
luc cells.
(D) Peritoneal macrophages from WT or tlr11/
mice were stimulated with Mono-Q fractions, and
IL-6 production was analyzed by ELISA.
Related to Figure S2.TLR11-stimulatory fraction from Mono Q column chromatog-
raphy of 8NU lysates was sequenced by mass spectrometry
and yielded E. coli flagellin as the primary component (Figures
S2C–S2E). Therefore, TLR11, which is highly enriched at epithe-
lial surfaces, including bladder (Zhang et al., 2004), kidney, and
small intestine (Figure S1A), is capable of recognizing flagellin
from enteropathogenic and uropathogenic bacteria. Taken
with the enhanced susceptibility of TLR11-deficient mice to
S. Typhimurium and UPEC infection, these data suggest nonre-
dundant roles for TLR5 and TLR11 in the recognition of flagel-
lated bacteria.
Recognition of Flagellin by TLR5 and TLR11
To directly examine whether flagellin responses depend on
TLR11, we purified recombinant S. Typhimurium flagellin to
homogeneity, followed by passage through polymyxin B sephar-
ose resin to remove contaminating LPS. We injected this purified
flagellin into WT and tlr11/mice and measured serum levels of
IL-6 and IL-12. TLR11 knockout (KO)mice produced significantly
less IL-6 and IL-12 following injection of recombinant flagellin
(Figure 3A). Consistent with previous reports (Feuillet et al.,
2006; Uematsu et al., 2006), production of serum IL-6 was also
partially reduced when flagellin was injected into TLR5 KO
animals (data not shown), suggesting that both can indepen-
dently recognize flagellin.
To further explore the role of TLR5 and TLR11 in the re-
cognition of S. Typhimurium flagellin, we generated C-terminally
epitope-tagged versions of TLR5 (TLR5-V5) and TLR11 (TLR11-
Flag). Using lysates from HEK293 T cells expressing TLR5,
TLR11, or both, we performed pull-downs with recombinant
polyhistidine-tagged S. Typhimurium flagellin. Flagellin was
captured by using nickel beads, and binding of TLR5 and
TLR11 was assessed by immunoblotting. Consistent with the
ability of TLR5 and TLR11 to activate cytokine expression in
response to flagellin, both TLRs were capable of interactingwith flagellin (Figure 3B). To examine whether TLR5 and TLR11
might interact with each other and hence act as a heterodimer
in cells in which they are coexpressed, we mixed Flag-tagged
TLR11 with V5-tagged TLR5 and HA-tagged TLR11. Interest-
ingly, TLR11 can form a heterodimer with TLR5 but can also
form homodimers (Figure S3A).
We had been intrigued by the increased resistance of mice
lacking TLR5 to infection by S. Typhimurium (Uematsu et al.,
2006) and wondered whether TLR11, given that it could signal
in macrophages lacking TLR5, might have a role in this resis-
tance. Different explanations have been advanced to explain
this phenomenon, including the possible influence of altered
commensal bacterial flora and enhanced IL-1b activity in the
TLR5 KOs (Carvalho et al., 2011; Vijay-Kumar et al., 2008). In
addition to epithelial cells, sentinel cells of the intestine include
lamina propria (LP), macrophages (Mfs), and dendritic cells
(DCs). We therefore analyzed TLR5 and TLR11 mRNA expres-
sion in these two cell types. Whereas LP-DCs express both
TLR5 and TLR11, we found that LP-Mfs express TLR11, but
not TLR5, which is consistent with previous reports (Means
et al., 2003; Uematsu et al., 2006) (Figure 3E, inset). Therefore
it is likely that, in LP-DCs, flagellin recognition is mediated by
both TLR5 and TLR11, possibly as a heterodimer, whereas
in LP-Mf, TLR11 homodimers recognize flagellin. Therefore,
although TLR11 and TLR5 both recognize flagellin and can
form a heterodimer, heterodimer formation is clearly not a
prerequisite for flagellin recognition, which is consistent with
the lack of TLR11 in humans.
We had noted that TLR11 is upregulated inmacrophages upon
exposure to S. Typhimurium or flagellin (Figure S3B). Therefore,
we decided to examine the expression of TLR5 and TLR11 in LP-
Mf before and after infection with S. Typhimurium. Consistent
with the in vitro data, we observed an increase in TLR11 mRNA
upon infection. Surprisingly, TLR11 mRNA was upregulated in
tlr5/ macrophages both before and, to a greater extent, afterCell 151, 590–602, October 26, 2012 ª2012 Elsevier Inc. 593
CE
D
B
F
A
Figure 3. Recognition of S. Typhimurium Flagellin by TLR5 and TLR11
(A) WT and tlr11/mice (n = 5) were injected intraperitoneally with recombinant S. Typhimurium flagellin, and 2 hr later, serum IL-6 and IL-12 were measured by
ELSIA. *p < 0.01.
(B) TLR5 and TLR11 were expressed in HEK293 cells for 48 hr, and TLR/flagellin complexes were formed by incubating cell lysates with His-tagged recombinant
S. Typhimurium flagellin (1 mg/ml) overnight at 4C. Binding was assessed by Ni-sepharose pull-down followed by western blotting with anti-Flag, anti-V5, and
anti-His antibodies.
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infection (Figures 3C and S3C). This suggests that, in tlr5/
mice, the LP-Mf are activated, most likely indirectly, and as
a result, the level of TLR11 is increased in these cells. Sorted
CD11b+ LP-Mf from tlr5/ mice express increased levels of
the activation markers CD86 and MHC class II after infection,
similar to the WT mice, which is consistent with the activated
status of these macrophages (Figure 3D). Consistent with
enhanced TLR11 expression in tlr5/ LP-Mf, these cells were
hyperresponsive to heat-killed S. Typhimurium (HKS) (Figure 3E)
and infection. Although there was a modest increase in basal
cytokine production observed in the unstimulated LP-Mf, only
the HKS-induced response was abrogated upon deletion of
TLR11 (Figure 3E). Therefore, hyperresponsiveness of TLR5/
LP-Mf to S. Typhimurium PAMPs required TLR11. These results
suggest that increased TLR11 expression in TLR5 KO macro-
phages leads to their enhanced activation and increased recruit-
ment of CD4 T cells to the lamina propria, thereby facilitating
clearance of Salmonella from these mice. This model suggests
that the TLR11 KO phenotype would be dominant during
S. Typhimurium infection. Indeed, tlr5//tlr11/ mice exhibit
enhanced lethality like tlr11/ mice (Figure 3F). Arguably, the
lethality of the double-KO mice and S. Typhimurium dissemina-
tion are further enhanced (Figure S3D), suggesting that loss of
TLR11 may reveal a protective role for TLR5.
TLR11 Knockout Mice Are Susceptible to Infection
by S. Typhi
The vast majority of animal studies on Salmonella have been
carried out by using S. Typhimurium, a Salmonella enterica
serovar that causes a typhoid-like disease only in mice. In
contrast, S. Typhi causes typhoid fever in humans but does
not infect mice (Tsolis et al., 1999). This lack of a convenient
small-animal model has prevented careful study of the immune
response to S. Typhi (Raffatellu et al., 2008). As a result, there
are significant outstanding questions regarding S. Typhi biology
and, especially, the host immune response to this important
pathogen. Consequently, development of effective vaccines
against S. Typhi has been significantly hampered. Although
oral S. Typhi vaccines exist, efficacy has been limited to 70%
(Levine et al., 1999, 2007); although more effective conjugate
vaccines are available, these are ineffective in young children
(Lin et al., 2001). Furthermore, the development of Salmonella
spp. as potential vaccine vectors is also hindered by the inability
to infect rodent models (Mestecky et al., 2008).
TLR11 is expressed in mice, but not humans, and we hypoth-
esized that expression of TLR11 might be responsible for pre-
venting infection by S. Typhi. Although S. Typhi is thought to
modulate expression of flagellin in order to evade recognition(C) Wild-type, tlr11/, and tlr5//tlr11/mice were challenged with S. Typhimu
were obtained by sorting (CD11CCD11b+ MHC-II+). RNA was prepared and an
(D) Lamina propria cells from above were analyzed for macrophage activation m
infected mice.
(E) Lamina propria macrophages and DCs were sorted from WT mice and analyz
and tlr5//tlr11/ mice were stimulated in vitro with heat-killed S. Typhimurium
ELISA.
(F) WT, tlr11/, and tlr5//tlr11/ mice (n = 8) were challenged with S. Typhim
Related to Figure S3.by the host, this occurs after engaging the epithelial barrier
(Arricau et al., 1998; Winter et al., 2008). Thus, expression of
TLR11 and recognition of S. Typhi at the epithelium in mice
may be a crucial determinant of murine resistance to S. Typhi.
To test this hypothesis, we orally administered S. Typhi to WT
and tlr11/ mice. As expected, WT mice were unaffected by
S. Typhi. In contrast, all of the tlr11/ mice were infected and
displayed significant mortality (Figure 4A). Infection of tlr11/,
but not WT, mice was accompanied by significant upregulation
of serum IL-12 (Figure 4B) and TNF (Figure 4C), suggesting
disseminated disease. Indeed, severe intestinal tissue damage
with areas of complete epithelial breakdown was observed in
tlr11/ mice (Figures 4D and 4E). Furthermore, bacterial
dissemination to various organs, along with high colony forming
units (CFU) load, was observed in tlr11/ mice (Figure 4F). We
also examined the presence of cell death in spleen and liver
sections in infected mice by using TUNEL staining and observed
increased TUNEL-positive cells in sections from tlr11/ mice
(Figure 4G). Although previous studies have shown mild differ-
ences in TLR5 responses to Salmonella sp. flagellin, these
results suggest that the lack of TLR11 in humans may be
a more crucial determinant of Salmonella susceptibility. Thus,
the host tropism of S. Typhi is restricted by a host-specific TLR.
Nontyphoidal Salmonella serovars (NTS) cause a very different
disease compared to typhoidal Salmonella serovars, such as
S. Typhi and S. Paratyphi. In humans, in whom NTS cause local
gastroenteritis and diarrhea, these bacteria do not breach the
epithelial barriers and are cleared by the mucosal immune
system. In contrast, S. Typhi overcomes the mucosal barrier
even in healthy adults and is disseminated to internal organs. A
feature of typhoid infection in humans is its persistence, where
the patient develops high fever for extended periods. We there-
fore wanted to test whether tlr11/ mice infected with S. Typhi
also developed fever. The pathogenic S. Typhi strain used in
these studies is well studied and characterized (S. Typhi-Ty2
pathogenic strain from ATCC 700931) and expresses the Vi
capsular antigen (Figure S4A), which is a major virulence factor
for S. Typhi. Tlr11/ mice infected with a relatively low dose
(CFU 106) of orally administered S. Typhi developed fever,
whereas, asexpected, theWTmicewereuninfected (FigureS4B).
Fever persisted for 3 weeks before dissipating. In contrast,
when the mice were infected with the normal, higher dose (CFU
5 3 108) of S. Typhi, the TLR11 KOs developed fever but then
developed sepsis around day 10 with hypothermia and death
(Figure S4C). Stool samples from the infected mice revealed
significantly increased levels of gross blood and bloody diarrhea
in the tlr11/ mice (Figure S4D). Careful examination of the
ileum, colon, and caecum of the infected tlr11/ mice showedrium, and 5 days later, mice were sacrificed, and lamina propria macrophages
alyzed for TLR5 and TLR11 expression by RT-PCR.
arkers (CD80, CD86, MHC-II, and CD40) by FACS. The blue traces are from
ed for TLR5 and TLR11 expression by RT-PCR (inset). Cells from WT, tlr11/,
, and IL-6 (upper graph) and IL-12 (lower graph) production was measured by
urium.
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Figure 4. Tlr11/ Mice Are Susceptible to Oral Infection with Salmonella Typhi
(A) Survival of WT and tlr11/ mice (n = 5 mice) orally infected with 109 CFU S. Typhi (S. Typhi-Ty2, ATCC 700931).
(B) Day 10 serum IL-12 p40 from mice orally infected with 109 CFU S. Typhi per mouse.
(C) ELISA analysis of serum TNF from mice orally infected with S. Typhi as in (B). *p < 0.01.
(D and E) (D) Histology of orally infected WT and tlr11/mice was assessed on day 10 postinfection by using small intestine sections, and (E) histological score
was plotted.
(F) S. Typhi dissemination detected by CFU per gram of tissue on LB plates from spleen, MLN, liver, and kidney.
(G) H&E staining and tunel staining of tissues from day 10 postinfection with S. Typhi. The arrows indicate tunel-positive cells.
Related to Figures S4 and S5.breaches in the epithelial layer that were likely responsible for the
bleeding that was observed (Figures S5A and S5B). Histology
from tlr11/ demonstrated evidence of disseminated disease
in spleen, kidney, and lung (Figures S5C and S5D).
During typhoid infection, the gallbladder is often colonized by
S. Typhi and can serve as a reservoir in chronic carriers, themost596 Cell 151, 590–602, October 26, 2012 ª2012 Elsevier Inc.notorious example of which was the case of Typhoid Mary.
Mice infected with S. Typhimurium can also show infection of
the gallbladder (Menendez et al., 2009). We examined the
gallbladders from tlr11/ mice infected with S. Typhi. Seven
days postinfection, we observed significant numbers of bacteria
in the gallbladders, both microscopically and upon culturing
JH I
A B C D
E F G
s
Figure 5. S. Typhi Infection of tlr11/ Mice Requires Flagellin
(A) TLR/flagellin complexes were formed by incubating cells expressing TLR11 or TLR5 with His-tagged recombinant S. Typhi flagellin. Binding was assessed by
Ni-sepharose pull-down followed by western blotting with anti-Flag, anti-V5, and anti-His antibodies.
(B) S. Typhimurium and S. Typhi flagellin were cloned in pET-15b vector, and flagellin was purified by affinity chromatography (inset). RAWNF-kB luciferase cells
were stimulated with increasing doses of flagellin and assayed for luciferase activity.
(C) WT, tlr11/, and tlr5//tlr11/ peritoneal macrophages were stimulated with flagellin (500 ng/ml), and supernatant IL6 was measured by ELISA.
(D) Aflagellate S. Typhi was obtained from the Salmonella Genome Stock Centre (SGSC; Calgary, Canada), examined for motility on soft agar plate, and grown in
a humid chamber overnight at 37C. Bacterial growth was measured from center and plotted.
(E) WT and tlr11/ mice (n = 5) were orally infected with flagellate or aflagellate Salmonella Typhi (5 3 108 CFU).
(F) Mice were sacrificed at day 10, and tissue CFU in spleen, kidney, liver, and lung was measured by using LB-agar plates. *p < 0.01.
(G) On day 10, serum cytokines were analyzed by ELISA.
(H) WT and tlr11/ mouse peritoneal macrophages were infected with S. Typhi at an MOI of 10 for 6 hr and stained with DAPI (indicated by arrows).
(I) Macrophages infected for 2 hr were washed three times, placed inmedia with 100 mg/ml gentamycin, and incubated for 4 hr.Macrophage lysates preparedwith
Triton X-100-containing media were plated on the LB agar plates to determine CFU.
(J) WT and tlr11/ mice (n = 8) were orally infected with flagellate and aflagellate Salmonella Typhimurium (CFU-108/ mice).
Related to Figure S6.the bacteria from the tissue (Figures S5E and S5F). Therefore,
tlr11/mice infected with S. Typhi show many of the hallmarks
of human typhoid.
Infection of TLR11 Knockout Mice by S. Typhi Is
Dependent on Flagellin
To test whether the flagellin from S. Typhi was also recognized
by TLR11, we cloned and expressed a His-tagged form of
flagellin from S. Typhi. In in vitro pull-down experiments, per-
formed in parallel with the S. Typhimurium flagellin pull-down
shown in Figure 3B, we find that S. Typhi flagellin is capableof binding both TLR5 and TLR11 similarly (Figure 5A). We puri-
fied flagellin from S. Typhimurium and S. Typhi by using nickel
affinity columns followed by passage through a polymyxin B
column to remove LPS (Figure 5B, inset) and tested their ability
to stimulate NF-kB activity in the RAW 264.7-luciferase reporter
cell line that does not express TLR5 (Figure 2B). Flagellins from
both spp. were equivalent in the ability to stimulate NF-kB in
these cells. To test the TLR dependence of flagellin recognition,
we stimulated peritoneal macrophages from WT, tlr11/,
tlr5/, and tlr11//tlr5/ mice and measured IL-6 production
by ELISA. The level of IL-6 produced was dramatically reducedCell 151, 590–602, October 26, 2012 ª2012 Elsevier Inc. 597
in cells from tlr11/mice, but not from tlr5/mice (Figure 5C),
which is consistent with the lack of significant expression of
TLR5 in macrophages (Means et al., 2003; Uematsu et al.,
2006).
As flagellin from both S. Typhi and S. Typhimurium are recog-
nized by TLR11, we wondered why mice would be resistant to
only S. Typhi. TLR11 is absent in humans, and interestingly,
similar to the situation in mice, S. Typhi does not infect a variety
of other species that coincidentally also express TLR11.
Sequencing efforts have revealed thatS. Typhi has a significantly
degraded genome that expresses far fewer virulence factors
compared to S. Typhimurium (Parkhill et al., 2001). Hence, a
possible explanation for the species-specific resistance to
S. Typhi by TLR11 would be the unique dependence of
S. Typhi on flagellin as a virulence factor. Consistent with such
a hypothesis, a previous study found minimal effects of the
loss of flagella on S. Typhimurium infection in mice, suggesting
that other virulence factors were substituting for the absence
of flagellin (Lockman and Curtiss, 1990; Schmitt et al., 2001). In
contrast, aflagellate S. Typhi exhibited defects in epithelial cell
invasion in vitro that were not solely due to lack of motility (Liu
et al., 1988). To directly test the role of flagellin in the infection
of mice by S. Typhi and S. Typhimurium, we obtained aflagellate
versions of both strains. We first ensured that the aflagellate
S. Typhi also expressed Vi antigen (Figure S4A). As expected,
the motility of aflagellate S. Typhi on a soft agar assay was
dramatically reduced (Figure 5D). We then compared the ability
of flagellated and aflagellated S. Typhi to infect WT and tlr11/
mice. Only tlr11/ mice developed lethal infection with
flagellated S. Typhi; however, these mice were unaffected by
aflagellated S. Typhi (Figure 5E). We also characterized the
mice infected with the aflagellated S. Typhi and observed
reduced dissemination (Figure 5F) and cytokine production (Fig-
ure 5G). These data, with previous in vitro experiments (Liu et al.,
1988), suggest a particular dependence ofS. Typhi on flagellin as
a key virulence factor in vivo.
Mice are ordinarily resistant to S. Typhi, even when introduced
by intravenous or intraperitoneal inoculation. The transplanta-
tion of mice with human immune cells can render mice suscep-
tible to S. Typhi infection by intraperitoneal inoculation, sug-
gesting that the host specificity of S. Typhi also results from
a requirement for human mononuclear cells (Firoz Mian et al.,
2011; Libby et al., 2010; Song et al., 2010). Our studies suggest
that TLR11 is critical for preventing infection by Salmonella Typhi
following the normal (oral) transmission route. However, to test
directly whether TLR11 also affects the ability of the bacteria
to infect macrophages, we isolated peritoneal macrophages,
which lack TLR5, from wild-type and TLR11 KO mice and
infected them with S. Typhi. The TLR11 KO macrophages
were infected with significantly greater numbers of bacteria as
determined by direct microscopic analysis (Figure 5H).
S. Typhi in infected tlr11/ macrophages was viable and could
be recovered from infected macrophages. Infected macro-
phages were incubated in gentamycin-containing media after
infection to kill noninternalized bacteria, followed by separating
and washing the cells and performing CFU assays (Figure 5I).
We also compared the ability of flagellated and aflagellated
S. Typhi to infect TLR11 KO peritoneal macrophages in culture598 Cell 151, 590–602, October 26, 2012 ª2012 Elsevier Inc.by using the same microscopic and gentamycin culture assays,
and we observed a clear dependence on flagellin for S. Typhi
infection of mouse macrophages (Figure S6A). Finally, we
wanted to test the role of TLR11 when mice were infected by
intraperitoneal injection of S. Typhi. It is well known that the
restriction against S. Typhi in mice is not due to a barrier effect,
as mice are even resistant to intraperitoneal infection (Collins
and Carter, 1978). Recent chimeric humanized mouse models
demonstrate that the host restriction in bone-marrow-derived
cells applies to systemically administered S. Typhi (Firoz Mian
et al., 2011; Libby et al., 2010; Song et al., 2010). Consistent
with the infection experiments in culture, S. Typhi did not cause
infection of WTmice, whereas the absence of TLR11 led to lethal
systemic infection, even with a low-dose infection (104 CFU per
animal) with dissemination of the bacteria to different organs
(Figures S6C and S6D). In contrast to S. Typhi, when oral
infections were performed with flagellated and aflagellated
S. Typhimurium, we observed significant and similar lethality in
WT and tlr11/ mice with the aflagellated S. Typhimurium (Fig-
ure 5J). These results suggest that other virulence factors present
in S. Typhimurium, but not in S. Typhi, mitigate the requirement
for flagellin and offer a plausible explanation for why S. Typhi,
but not S. Typhimurium, exhibits strict human host restriction.
TLR11 KO Mice Can Be Immunized against Infection
by S. Typhi
Analysis of the tlr11/mice infected with S. Typhi suggests that
TLR11 provides effective immune responses at the intestinal
epithelial barrier, preventing entry and subsequent dissemina-
tion of the bacteria. As S. Typhi are gram-negative bacteria
that express numerous other PAMPs and as the immune system
of these mice is not otherwise compromised, we assumed that
adaptive immune responses to injected S. Typhi would be main-
tained. The more delayed disease course in tlr11/ mice
compared with recent humanized mouse models (Libby et al.,
2010) is consistent with tlr11/ mice having otherwise normal
immune systems. The recovery of mice that are given low-
dose oral infection and exhibit a typhoid-like disease course
further distinguishes the tlr11/ mice as an S. Typhi disease
model. These findings led us to speculate that tlr11/ mice
would be a useful model for vaccine development. We therefore
immunized wild-type and tlr11/ mice by injecting heat-killed
S. Typhi intraperitoneally, with the first injection followed by
four booster injections at 4 day intervals. As a control, the unim-
munized mice were injected with PBS. Fourteen days after the
final booster injection (i.e., 30 days after the first injection), the
mice were given live S. Typhi (CFU 53 108) orally and monitored
for 3 weeks. Whereas all unimmunized tlr11/mice died by day
20 of infection, immunization provided complete protection
against S. Typhi infection in tlr11/ mice (Figure 6A). There
was very little dissemination of S. Typhi, and immunized tlr11/
mice gained weight similar to WT mice (Figures 6B and 6C).
Immunization of tlr11/ mice also reduced cytokine responses
to levels that were comparable to those of WT mice (Figure 6D).
We examined the antibodies in the immunized animals and
detected elevated IgG1 and IgA (Figures 6G and 6H). Prolifera-
tion of CD4+ T cells was augmented (Figure 6E), whereas the
number of CD62L low/CD44 high cells was significantly
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Figure 6. Generation of Protective Immunity in tlr11/ Mice by Immunization
(A) WT and tlr11/mice immunized with or without 108 CFU equivalents of heat-killed S. Typhi (HKS) at days 30,26,22,18, and14 were challenged by
oral administration of 5 3 108 CFU live S. Typhi on day 0 (n = 5 per group).
(B) Day 10 postinfection CFU from spleen, liver, and kidney homogenates measured by plating on LB agar plates.
(C) Weight of WT and tlr11/ mice injected with or without heat-killed S. Typhi and subsequently orally challenged with live S. Typhi as in (A) (n = 5).
(D) TNF ELISA performed from serum samples collected at day 10 postinfection of HKS-immunized versus control nonimmunized mice as in (A). *p < 0.01.
(E) Proliferation of Cell-Tracker-labeled CD4 T cells cultured in vitro for 48 hr with antigen-presenting cells simulated with HKS was analyzed by FACS.
(F) Memory phenotype of splenic T cells from tlr11/ mice, either nonimmunized or HKS immunized, was assessed by analysis of CD44 and CD62L by FACS.
(G and H) Serum IgG1 and IgA measured by ELISA from uninfected animals immunized as in (A).
(I) Survival of WT and tlr11/ mice infected with S. Typhi. The tlr11/ mice were either nonimmunized or HKS immunized or were injected with serum (100 ml)
from immunized WT mice before challenge with live, orally administered S. Typhi (CFU 5 3 108).increased in immunized animals (Figure 6F), suggesting devel-
opment of strong memory responses that are critical for
successful vaccination.
Finally, to see whether generated immunity to S. Typhi could
be transferred to an unimmunized TLR11 KO, we isolated serum
from theWTmice immunized with heat-killed S. Typhi and trans-
ferred it to uninfected TLR11 KO mice. The recipient mice were
then infected with live S. Typhi, and we observed significant
protection against lethality in these mice (Figure 6I). This result
strongly suggests that the TLR11 KO mice are likely to be an
excellent model to study protective immune responses to
S. Typhi, and hence facilitate efforts to develop more effective
human vaccines.DISCUSSION
In this study, we report that the nonhuman TLR, TLR11, recog-
nizes flagellin and helps prevent oral Salmonella spp. infection
and dissemination in mice. Interestingly, S. Typhi, an obligate
human pathogen that does not infect WT mice, can efficiently
infect tlr11/ mice. This represents a clear demonstration of
pathogen host restriction determined by species-restricted
TLR expression. As such, tlr11/ mice resemble mice with a
humanized innate immune system, at least with respect to
recognition ofSalmonella flagellin. Thus, absence of TLR11 abol-
ishes the innate immunity that normally prevents S. Typhi infec-
tion. This restriction likely occurs at the level of tissue-residentCell 151, 590–602, October 26, 2012 ª2012 Elsevier Inc. 599
macrophages, which express high levels of TLR11 and are
nonpermissive forS. Typhi infection. Given that TLR11 is also ex-
pressed in small intestinal epithelial cells as well as in dendritic
cells, it is possible that TLR11 acts to both promote barrier
responses against Salmonella spp. and to augment systemic
adaptive and innate responses after the epithelial barrier is
breached. The relative contribution of various TLR11-expressing
cellular compartments remains to be fully explored. Neverthe-
less, in the absence of TLR11, Salmonella spp. disseminate
more readily to other organs, including gallbladder, spleen, liver,
and kidney. Upon infection with a high inoculum, there is signif-
icant epithelial damage, and a robust disseminated infection is
established. S. Typhi PAMPs detected by TLRs such as TLR2,
TLR4, and TLR5 are likely to lead to systemic cytokine produc-
tion and septic shock.
In the context of a low-dose infection of otherwise immuno-
competent tlr11/ mice, a more classical resolving typhoidal
disease is observed. In this context, other aspects of the innate
immune system are likely to be protective. Hence, the tlr11/
mice should allow the contribution of TLR5 and other com-
ponents of the innate and adaptive immune response to be
addressed in a small-animal model that more closely mimics
the complement of innate Salmonella sensors present in
humans. It is possible that, as for S. Typhimurium infection, in
which loss of TLR5 further sensitizes TLR11 KO animals, tlr11/
mice may reveal that TLR5 is a relevant sensor of S. Typhi. The
ability of tlr11/ mice to respond normally to internalized
bacteria means that they can be immunized by injection of
heat-killed S. Typhi. The protective immunity generated in immu-
nized tlr11/ mice is highly effective and completely blocks
infection upon subsequent oral challenge with live bacteria. The
ability to infect and successfully vaccinate the TLR11 KO means
that these mice represent a mouse model for S. Typhi infection
and should significantly facilitate future research into both the
pathobiology of this important pathogen and the development
of effective vaccination strategies against S. Typhi in humans.
Toll-like receptors have emerged as critical sensory mecha-
nisms for recognizing and responding to infectious microbes.
Although most TLRs are shared between humans and other
species such as mice, a subclass that includes TLR11, 12, and
13 is not expressed in humans. TLR11 is expressed in many
species such as birds, dogs, and cows but is absent in humans.
Previous studies have shown that TLR11 recognizes profilin,
a protein ligand from the apicomplexan parasite Toxoplasma
gondii, and plays a critical role in the mounting of innate immune
responses to this organism (Yarovinsky et al., 2005). In addition,
TLR11 was also shown to specifically respond to uropathogenic
E. coli strains that typically infect the urogenital tract, causing
urinary tract infections (Zhang et al., 2004). The expression of
TLR11 in epithelial cells, as well as macrophages and dendritic
cells, likely explains its involvement in mediating responses to
these different pathogens. The studies presented in this report
show that TLR11 recognizes flagellin from both the UPEC strain
8NU and Salmonella spp. In this regard, it is particularly inter-
esting to note that there are several important flagellated entero-
pathogenic bacteria—for example, enteropathogenic E. coli
(Mohawk and O’Brien, 2011) and Campylobacter jujuni (Young
et al., 2007)—for which mouse models do not recapitulate600 Cell 151, 590–602, October 26, 2012 ª2012 Elsevier Inc.human disease. Instead, many studies must be carried out by
using immunocompromised neonatal mice, colonization of
germ-free and streptomycin-treated mice, massive bacterial
doses, nonphysiological routes of administration, ormore limited
models such as the rabbit ileal loop or in vitro models. Although
these and other approaches have proven extremely useful, they
also have significant limitations, most notably for the study of
host immunity and for vaccine development. Unlike other animal
models in which conserved aspects of the innate immune
response have been removed, such as MyD88- or TLR4-
deficient mice, the tlr11/ mice maintain expression of all
conserved components of the innate and adaptive immune
system. As such, we speculate that tlr11/mice will be a useful
animal model to study the microbiology and immunology of
a wide variety of flagellated human pathogens andwill also prove
useful in vaccine development.
EXPERIMENTAL PROCEDURES
Experimental Animals
Tlr11/ mice (Zhang et al., 2004) were backcrossed to the C57/BL6
background (Jackson Laboratories, Bar Harbor, ME) for more than ten gener-
ations. Mice used in experiments were generated by crossing tlr11/+ mice.
Many experiments utilized WT and KO littermates, whereas in other experi-
ments, mice produced by crossing TLR11 KO males and females and WT
males and females, obtained from the first breeding, were used. Animals
used for experiments were age and sex matched and were bred and housed
in specific pathogen-free conditions (Yale University and Columbia University).
All mouse protocols were approved by IACUC, Yale University, and Columbia
University.
Reagents and Antibodies
LPS 0111:B4 was from Sigma (St. Louis, MO). Recombinant flagellin produced
in BL21 was purified by His-affinity chromatography and polymyxin B (Detoxi
Gel; Thermo). Purified flagellin from mammalian cells was kindly provided by
Dr. Andrew Gewirtz (Emory University; McSorley et al., 2002). Bacterial strains
were S. Typhi (ATCC-700931), Salmonella Typhimurium (SL1344), and GFP-
Salmonella strain (SL1344). Aflagellate S. Typhimurium (SL-1344; Aflagellate
fliC fljBfliC::Tn10 > fljB5001::MudJ) was from Dr. Louise Teel (Uniformed
Services University of the Health Sciences). Aflagellate S. Typhi Ty2 [SA4717
(fliC::Tn10—Fli()] was from the Salmonella Genetic Stock Center (Calgary,
Canada). Uropathogenic E. coli 8NU was from Dr. D. Klumpp (Northwestern
University, IL).
Purification of the S. Typhimurium TLR11 Ligand
S. Typhimurium (SL1344) was grown overnight at 37C without shaking,
collected by centrifugation, washed once in 10 mM Tris (pH 8), and homoge-
nized in a Warring Blender for 53 10 s followed by heating at 60C for 30 min.
The resulting product was centrifuged at 10,000 3g for 30 min, and the
supernatant was ultracentrifuged at 100,000 3g for 60 min. The resulting
supernatant was treated with polymyxin B (Thermo/Pierce), applied to
a DEAE Sephacel column, and eluted by step elution with 250 and 500 mM
NaCl. Dialyzed fractions were assessed by NF-kB luciferase reporter assay,
and fractions of interest were pooled and subjected to CMSepharose chroma-
tography. Fractions containing peak activity (flow through) were applied to
Mono Q column and eluted with a linear 50–500 mM NaCl gradient (AKTA,
GE biosciences). Fractions containing stimulatory activity were resolved by
SDS-PAGE and visualized by Coomassie. A single band coeluting with the
TLR11 stimulatory activity was excised and subjected to in-gel tryptic digest
and MS analysis (Columbia University Protein Core Facility).
mRNA Expression
Total RNA was isolated using Trizol (Invitrogen), and 1 mg of RNA was used for
RT. One-tenth of this reaction was used as a template for PCR amplification
with Taq polymerase for 30 cycles at 94C for 1 min, 55C for 1 min, and 72C
for 1 min. Primer sequences are in the Supplemental Information.
In Situ Hybridization
TLR11 cDNA fragments used as probes were amplified by using specific
primers (Supplemental Information) to create a 450 bp fragment and subcl-
oned into the pcDNA3 vector. Sense probes were prepared after linearization
with EcoRI and transcription with SP6 polymerase; antisense probes were
prepared after linearization with XbaI and transcription with T7 polymerase.
In situ hybridization was performed as described previously (Zhang et al.,
2004).
NF-kB Luciferase Assays
RAW264.7 cells stably transected with a NF-kB luciferase reporter construct
pBIIX-luc (Raw-kB-luc) were plated and, after 24 hr, were stimulated with
20 ng/ml of LPS or 1 mg /ml of flagellin for 6 hr. Luciferase activity was
measured according to the manufacturer’s instructions (Promega).
Flow Cytometry and Cell Isolation
Cells were stained by using the antibodies described (e-Biosciences or BD)
and analyzed on a BD LSR-II. Analysis was performed with FlowJo software.
For cell proliferation, splenocytes were plated in 96-well plates, stimulated
with heat-killed Salmonella for 72 hr, and analyzed for cell proliferation by using
Cell Tracker Red (Invitrogen) according to the manufacturer’s instructions.
Thioglycollate-elicited macrophages (Rao et al., 2010) and lamina propria cells
(Denning et al., 2007) were isolated frommice under sterile conditions by using
established protocols (see Supplemental Information). Lamina propria cells
were sorted by using a FACS ARIA at the Microbiology and Immunology
Core Facility, Columbia University.
ELISA Experiments
For in vitro ELISAs, peritoneal macrophages were cultured in RPMI1640 10%
FBS, and TNF, IL-12, and IL-6 were measured. For in vivo ELISAs, WT and
tlr11/ mice (n = 5) were injected i.p. with 30 mg of recombinant flagellin
and bled at 2 hr, and serum IL-6 and IL-12p40 levels were measured. To
assess cytokine production during infection, the same strains of mice were
orally infected with S. Typhimurium or S. Typhi, surviving animals were bled,
and serum IL-12p40 and TNF, IL6, IgG1, or IgA levels were assessed by ELISA
on d5 postinfection for S. Typhimurium and day 8–10 postinfection for
S. Typhi. ELISA kits were from BD Bioscience (San Jose, CA).
In Vivo Infection and Immunization
Wild-type and tlr11/ mice were orally infected with S. Typhimurium (108) or
Salmonella Typhi (53 108 or 53 109) using a gavage needle unless otherwise
indicated. For immunization, WT and tlr11/ mice were immunized by i.p.
injection of heat-killed S. Typhi (108 CFU equivalents per animal) five times
at 4 day intervals and challenged orally with live S. Typhi at 14 days after the
last immunization. Survival was monitored by daily observation, and Kaplan
Meier survival graphs were generated (Prism, GraphPad). n = 5 mice were
taken for each condition unless otherwise indicated; significance is as given
and was calculated in Prism.
Histology
Tissues were harvested and then sectioned and H&E stained at Yale or
Columbia histology core facilities. Images were captured by using a Zeiss
Imager-M2. Tissue histology sections were examined, and histological grading
was performed by a GI pathologist at Yale University. Sections were scored as
follows: 0, normal; 1, normal with focal epithelial loss; 2, normal with mild
surface epithelial loss; 3, partial necrosis and diffuse epithelial loss; 4, total
necrosis.
CFU
Bacterial burden was measured as follows: tissues were harvested and
homogenized at 1 gm per ml equivalent in LB and serially diluted 1:10 in LB,
and 100 ml was plated on LB plates. For S. Typhimurium CFU determination,
LB plates were supplemented with streptomycin. After 16 hr, colonies werecounted; data are presented as mean ±SD of triplicate samples and are
representative of at least three independent experiments.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures and
six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.cell.2012.08.042.
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